Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258791
Status:
WITHDRAWN
Last Update Posted:
2012-09-25
First Post:
2005-11-24
Brief Title:
Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy ECT Headache
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
Effects of Pretreatment With Ibuprofen in Post- ECT Headache
Status:
WITHDRAWN
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
first postponed then cancelled as national drug authority changed requirements
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity
Detailed Description:
The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment
Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally blinded to patient physician and treatment team
Patients will be asked about their headache with a visual analogue scale VAS 2 hours prior to and within 2 hours after treatment 2-month 6- month and 1 year follow-up 5
Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally blinded to patient physician and treatment team
Patients will be asked about their headache with a visual analogue scale VAS 2 hours prior to and within 2 hours after treatment 2-month 6- month and 1 year follow-up 5
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None